Product
Genetic and Epigenetic Analysis
1 clinical trial
5 indications
Indication
Opioid-use DisorderIndication
Neonatal Abstinence SyndromeIndication
PregnancyIndication
High-riskIndication
Alcohol Use DisorderClinical trial
Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant WomenStatus: Recruiting, Estimated PCD: 2024-09-01